Greenwich Lifesciences Inc 's

• GLSI's Stock Performance relative to its Competitors

Zymeworks Inc Share Performance +67.09% One Year

Zymeworks Inc Profile Zymeworks Inc is a biotechnology company that operates on a licensing and collaboration business model. They primarily generate revenue through partnerships and collaborations with pharmaceutical and biotechnology companies, providing access to their proprietary drug development platform and expertise in protein engineering. This enables them to advance the development of novel bi-specific antibodies and therapeutic proteins for the treatment of various diseases and medical conditions. More about Zymeworks Inc 's Market Share

Ocean Biomedical Inc Share Performance -38.46% This Year

Ocean Biomedical Inc Profile Ocean Biomedical develops biopharmaceutical products licensed from research institutions. More about Ocean Biomedical Inc 's Market Share

Nextcure Inc Share Performance +221.46% This Quarter

Nextcure Inc Profile NextCure Inc is a biopharmaceutical company that operates with a unique business model. They focus on discovering and developing novel immunomedicines to treat various forms of cancer and other immune-related diseases. With a focus on developing innovative therapies that target immune cells, NextCure aims to provide effective and personalized treatment options for patients in need. More about Nextcure Inc 's Market Share

Novartis Ag Share Performance -0.73% This Year

Novartis Ag Profile Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products. More about Novartis Ag's Market Share

Nuvalent Inc Share Performance +0.05% Over The Past 5 Days

Nuvalent Inc Profile Nuvalent Inc's business model entails developing innovative pharmaceutical solutions utilizing its proprietary technology and expertise. More about Nuvalent Inc 's Market Share

Sources: Greenwich Lifesciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 2:28 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Greenwich Lifesciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.